| Reference | Name | Unity | Provider | Aplication | Clonality | Host | Reactivity | Price | Tech.Sheet |
|---|---|---|---|---|---|---|---|---|---|
| Ab01738-10.29 | Anti-BAZ2B [RAB-C266] | 100 ug | Absolute Antibody | IP-MS; IF | Human | Request Quotation | Request | ||
| Ab00266-23.0 | Anti-SARS-CoV S glycoprotein [S225] | 200 ug | Absolute Antibody | ELISA; NTRL | SARS Coronavirus | Request Quotation | Request | ||
| Ab02434-10.3 | Anti-B7-H3 [2D6] | 200 ug | Absolute Antibody | ELISA | Human | Request Quotation | Request | ||
| Ab01735-10.29-BS | Anti-ATF7 [RAB-S27] | 1 mg | Absolute Antibody | FC; spiked-IP; IP-MS; IF | Human | Request Quotation | Request | ||
| Ab03305-10.3-BT | Anti-ATRX [20A2] | 1 mg | Absolute Antibody | IHC; WB; ELISA | Human | Request Quotation | Request | ||
| Ab00276-23.0-BT | Anti-HIV-1 GP120 [HR10] | 1 mg | Absolute Antibody | NTRL | HIV-1 | Request Quotation | Request | ||
| Ab03305-2.3-BT | Anti-ATRX [20A2] | 1 mg | Absolute Antibody | IHC; WB; ELISA | Human | Request Quotation | Request | ||
| Ab00295-7.1 | Anti-Ly6G [1A8] | 200 ug | Absolute Antibody | FC; depletion | Mouse | Request Quotation | Request | ||
| Ab00279-22.0 | Anti-EGFR [C225 (Cetuximab)] | 200 ug | Absolute Antibody | Block; FC | Human | Request Quotation | Request | ||
| Ab00884-1.32-BS | Anti-B7-H3 [MJ18] | 1 mg | Absolute Antibody | FC; Block | Mouse | Request Quotation | Request | ||
| Ab00294-1.1-BT | Anti-Phosphotyrosine [PY20] | 1 mg | Absolute Antibody | WB; IF; IHC-P; IHC-FoFr; IP | Other | Request Quotation | Request | ||
| Ab00279-3.0 | Anti-EGFR [C225 (Cetuximab)] | 200 ug | Absolute Antibody | Block; FC | Human | Request Quotation | Request | ||
| Ab00288-1.1-BT | Anti-CD32 [AT10] | 1 mg | Absolute Antibody | FC | Human | Request Quotation | Request | ||
| Ab00271-23.0 | Anti-HIV-1 GP41 [HGF24] | 200 ug | Absolute Antibody | NTRL | HIV-1 | Request Quotation | Request | ||
| Ab00279-20.0 | Anti-EGFR [C225 (Cetuximab)] | 50 ug | Absolute Antibody | Block; FC | Human | Request Quotation | Request | ||
| Ab00295-2.0-VXL | Anti-Ly6G [1A8] | 10 mg | Absolute Antibody | FC; depletion | Mouse | Request Quotation | Request | ||
| Ab00294-22.0 | Anti-Phosphotyrosine [PY20] | 200 ug | Absolute Antibody | WB; IF; IHC-P; IHC-FoFr; IP | Other | Request Quotation | Request | ||
| Ab00302-1.1 | Anti-CD44 (Indian blood group) [SAIC-01B-4D8] | 200 ug | Absolute Antibody | ELISA; WB; immunoMRM | Human | Request Quotation | Request | ||
| Ab01345-10.3 | Anti-Band 3/CD233 [Q1/156] | 200 ug | Absolute Antibody | IHC; IF; IP; WB | Human | Request Quotation | Request | ||
| Ab00302-1.1-BT | Anti-CD44 (Indian blood group) [SAIC-01B-4D8] | 1 mg | Absolute Antibody | ELISA; WB; immunoMRM | Human | Request Quotation | Request | ||
| Ab00292-24.1-BT | Anti-IgM [M15/8] | 500 ug | Absolute Antibody | ELISA; FC; IHC-Fr; IP; block | Human | Request Quotation | Request | ||
| Ab03125-10.29 | Anti-BCMA [13A4] | 100 ug | Absolute Antibody | ELISA; FC | Human | Request Quotation | Request | ||
| Ab00278-1.1-VPS | Anti-Nerve Growth Factor [alphaD11] | 25 mg | Absolute Antibody | IF; Block; ELISA; IHC | Rat; Mouse | Request Quotation | Request | ||
| Ab00256-23.0-BT | Anti-SARS-CoV S glycoprotein [S109] | 1 mg | Absolute Antibody | ELISA; NTRL | SARS Coronavirus | Request Quotation | Request | ||
| Ab00283-13.0-BT | Anti-CD33 [hP67.6 (Gemtuzumab)] | 1 mg | Absolute Antibody | FC; IF | Human | Request Quotation | Request | ||
| Ab00884-1.32 | Anti-B7-H3 [MJ18] | 100 ug | Absolute Antibody | FC; Block | Mouse | Request Quotation | Request | ||
| Ab01733-10.29-BT | Anti-ATF1 [RAB-T55] | 500 ug | Absolute Antibody | FC; spiked-IP; IF | Human | Request Quotation | Request | ||
| Ab01737-10.29-BT | Anti-BAZ2A [RAB-C506] | 500 ug | Absolute Antibody | FC; spiked-IP; IF | Human | Request Quotation | Request | ||
| Ab00279-7.1-BT | Anti-EGFR [C225 (Cetuximab)] | 1 mg | Absolute Antibody | Block; FC | Human | Request Quotation | Request | ||
| Ab00279-8.1-BT | Anti-EGFR [C225 (Cetuximab)] | 1 mg | Absolute Antibody | Block; FC | Human | Request Quotation | Request | ||
| Ab00304-1.1-BT | Anti-XPNPEP1 [SAIC-07B-14] | 1 mg | Absolute Antibody | ELISA; WB; immunoMRM | Human | Request Quotation | Request | ||
| Ab00269-1.1 | Anti-Norovirus GII.4 [NVB43.9] | 200 ug | Absolute Antibody | NTRL; Block | Norovirus | Request Quotation | Request | ||
| Ab00257-10.0 | Anti-SARS-CoV S glycoprotein [S110] | 200 ug | Absolute Antibody | ELISA; NTRL | SARS Coronavirus | Request Quotation | Request | ||
| Ab00276-10.0-BT | Anti-HIV-1 GP120 [HR10] | 1 mg | Absolute Antibody | NTRL | HIV-1 | Request Quotation | Request | ||
| Ab03125-10.29-BS | Anti-BCMA [13A4] | 1 mg | Absolute Antibody | ELISA; FC | Human | Request Quotation | Request | ||
| Ab00278-6.1-VPB | Anti-Nerve Growth Factor [alphaD11] | 100 mg | Absolute Antibody | IF; Block; ELISA; IHC | Rat; Mouse | Request Quotation | Request | ||
| Ab00255-23.0-BT | Anti-pre-fusion conformation of HRSV F protein [RSB43] | 1 mg | Absolute Antibody | IF; NTRL | Respiratory Syncytial Virus (RSV) | Request Quotation | Request | ||
| Ab00524-10.3 | Anti-Basigin [Ab-1] | 200 ug | Absolute Antibody | ELISA; Block | Human | Request Quotation | Request | ||
| Ab03334-10.3 | Anti-Basal cell Cytokeratin [RCK103] | 100 ug | Absolute Antibody | FC; IHC | Human; Canine; Chicken; Guinea Pig; Hamster; Quail | Request Quotation | Request | ||
| Ab00277-10.0-BT | Anti-HIV-1 GP120 [HR12] | 1 mg | Absolute Antibody | NTRL | HIV-1 | Request Quotation | Request | ||
| Ab00884-2.3-BT | Anti-B7-H3 [MJ18] | 1 mg | Absolute Antibody | FC; Block | Mouse | Request Quotation | Request | ||
| Ab00283-10.0 | Anti-CD33 [hP67.6 (Gemtuzumab)] | 200 ug | Absolute Antibody | FC; IF | Human | Request Quotation | Request | ||
| Ab02433-3.3-BT | Anti-B7-H3 [A9] | 1 mg | Absolute Antibody | ELISA | Human | Request Quotation | Request | ||
| Ab00275-10.0 | Anti-HIV-1 GP41 [HK20] | 200 ug | Absolute Antibody | NTRL | HIV-1 | Request Quotation | Request | ||
| Ab00287-6.1-BT | Anti-CD32 [AT130-5] | 1 mg | Absolute Antibody | IHC | Mouse | Request Quotation | Request | ||
| Ab00295-23.0 | Anti-Ly6G [1A8] | 200 ug | Absolute Antibody | FC; depletion | Mouse | Request Quotation | Request | ||
| Ab00268-23.0-BT | Anti-SARS-CoV S glycoprotein [S230] | 1 mg | Absolute Antibody | ELISA; NTRL | SARS Coronavirus | Request Quotation | Request | ||
| Ab00257-3.0-BT | Anti-SARS-CoV S glycoprotein [S110] | 1 mg | Absolute Antibody | ELISA; NTRL | SARS Coronavirus | Request Quotation | Request | ||
| Ab00278-1.1 | Anti-Nerve Growth Factor [alphaD11] | 200 ug | Absolute Antibody | IF; Block; ELISA; IHC | Rat; Mouse | Request Quotation | Request | ||
| Ab00273-23.0-BT | Anti-HIV-1 GP120 [HGZ1] | 1 mg | Absolute Antibody | NTRL | HIV-1 | Request Quotation | Request |